Format
Items per page
Sort by

Send to:

Choose Destination

Results: 14

1.

Mutational profile of advanced primary and metastatic radioactive iodine-refractory thyroid cancers reveals distinct pathogenetic roles for BRAF, PIK3CA, and AKT1.

Ricarte-Filho JC, Ryder M, Chitale DA, Rivera M, Heguy A, Ladanyi M, Janakiraman M, Solit D, Knauf JA, Tuttle RM, Ghossein RA, Fagin JA.

Cancer Res. 2009 Jun 1;69(11):4885-93. doi: 10.1158/0008-5472.CAN-09-0727.

PMID:
19487299
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due to BRAF and p53 mutations.

Quiros RM, Ding HG, Gattuso P, Prinz RA, Xu X.

Cancer. 2005 Jun 1;103(11):2261-8. Review.

PMID:
15880523
[PubMed - indexed for MEDLINE]
Free Article
3.

Genetic alterations in the phosphatidylinositol-3 kinase/Akt pathway in thyroid cancer.

Xing M.

Thyroid. 2010 Jul;20(7):697-706. doi: 10.1089/thy.2010.1646. Review.

PMID:
20578891
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

From nodule to differentiated thyroid carcinoma: contributions of molecular analysis in 2012.

Albarel F, Conte-Devolx B, Oliver C.

Ann Endocrinol (Paris). 2012 Jun;73(3):155-64. doi: 10.1016/j.ando.2012.03.002. Epub 2012 Apr 13. Review.

PMID:
22503804
[PubMed - indexed for MEDLINE]
5.

BRAF mutation in papillary thyroid carcinoma: pathogenic role and clinical implications.

Tang KT, Lee CH.

J Chin Med Assoc. 2010 Mar;73(3):113-28. doi: 10.1016/S1726-4901(10)70025-3. Review.

PMID:
20230995
[PubMed - indexed for MEDLINE]
6.

[BRAF gene mutation in thyroid cancer].

KopczyƄska E, Junik R, Tyrakowski T.

Pol Merkur Lekarski. 2006 Feb;20(116):210-3. Review. Polish.

PMID:
16708643
[PubMed - indexed for MEDLINE]
7.

Encapsulated malignant follicular cell-derived thyroid tumors.

Ghossein R.

Endocr Pathol. 2010 Dec;21(4):212-8. doi: 10.1007/s12022-010-9141-8. Review.

PMID:
21088998
[PubMed - indexed for MEDLINE]
8.

BRAF mutation in papillary thyroid cancer: pathogenic role, molecular bases, and clinical implications.

Xing M.

Endocr Rev. 2007 Dec;28(7):742-62. Epub 2007 Oct 16. Review.

PMID:
17940185
[PubMed - indexed for MEDLINE]
9.

Role of BRAF in thyroid oncogenesis.

Caronia LM, Phay JE, Shah MH.

Clin Cancer Res. 2011 Dec 15;17(24):7511-7. doi: 10.1158/1078-0432.CCR-11-1155. Epub 2011 Sep 7. Review.

PMID:
21900390
[PubMed - indexed for MEDLINE]
Free Article
10.

Molecular pathology of thyroid cancer: diagnostic and clinical implications.

Fagin JA, Mitsiades N.

Best Pract Res Clin Endocrinol Metab. 2008 Dec;22(6):955-69. doi: 10.1016/j.beem.2008.09.017. Review.

PMID:
19041825
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

An update on molecular biology of thyroid cancers.

Omur O, Baran Y.

Crit Rev Oncol Hematol. 2014 Jun;90(3):233-52. doi: 10.1016/j.critrevonc.2013.12.007. Epub 2013 Dec 18. Review.

PMID:
24405857
[PubMed - indexed for MEDLINE]
12.

Differentiated Thyroid Cancer: Focus on Emerging Treatments for Radioactive Iodine-Refractory Patients.

Gruber JJ, Colevas AD.

Oncologist. 2015 Feb;20(2):113-126. Epub 2015 Jan 23. Review.

PMID:
25616432
[PubMed - as supplied by publisher]
13.

Metastatic mechanisms in follicular cell-derived thyroid cancer.

Phay JE, Ringel MD.

Endocr Relat Cancer. 2013 Oct 14;20(6):R307-19. doi: 10.1530/ERC-13-0187. Print 2013 Dec. Review.

PMID:
24036131
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Molecular pathogenesis and targeted therapies in well-differentiated thyroid carcinoma.

Kim JG.

Endocrinol Metab (Seoul). 2014 Sep;29(3):211-6. doi: 10.3803/EnM.2014.29.3.211. Review.

PMID:
25309777
[PubMed]
Free PMC Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk